Title : The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese patients without Diabetes: A Systematic Review and Meta-Analysis.

Pub. Date : 2022 May 5

PMID : 35512849






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The results showed that the treatment of overweight/obese patients without diabetes with GLP-1RAs including liraglutide, exenatide and semaglutide significantly achieved greater weight loss than placebo (WMD=-5.39,95%CI (-6.82, -3.96)) and metformin (WMD=-5.46,95%CI (-5.87, -5.05)). Metformin glucagon like peptide 1 receptor Homo sapiens